Status:
UNKNOWN
Polyneuropathy and COVID-19
Lead Sponsor:
Fondazione Don Carlo Gnocchi Onlus
Collaborating Sponsors:
Fondazione Poliambulanza Istituto Ospedaliero
Fondazione Salvatore Maugeri
Conditions:
COVID-19
Polyneuropathies
Eligibility:
All Genders
18+ years
Brief Summary
Since the onset of the Coronavirus pandemic disease 2019 (COVID-19), the Lombardy region and in particular the territory of the province of Brescia has been heavily affected. Current data show that th...
Detailed Description
The study will be conducted in all the centers considered following the same protocol based on data collection of COVID-19 patients with an associated diagnosis of polyneuropathy. Demographic informat...
Eligibility Criteria
Inclusion
- Patients with a confirmed diagnosis of Sars-Cov2 infection, regardless of the degree of severity and negative results to 2 consecutive nasopharyngeal swabs.
- Diagnosis of Polyneuropathy is defined clinically and/or by electromyographic examination.
- Older age
- Both sexes
Exclusion
- Presence of disabling conditions affecting the musculoskeletal system.
- Ischemic/hemorrhagic stroke
- Neurodegenerative diseases
- Presence of rheumatic and inflammatory diseases.
- Chronic diseases of the respiratory system.
- Hemodynamic instability
- Cognitive impairment (Mini-Mental State Examination \<18)
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2022
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05188690
Start Date
June 1 2021
End Date
July 31 2022
Last Update
January 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro "E. Spalenza - Don Gnocchi"
Rovato, Italy, 25038